SUDARSHAN · SUDARSHAN PHARMA INDUSTRIES LI · Financials
Market Cap
8.34B INR
Shares
254.47M
Volume · Nov 13
5659
Avg daily vol (3M)
289.32K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
7.03B
+39.2%
FY2026
Net Income
233.03M
+46.7%
FY2026
Operating Cash Flow
-22.99M
+91.2%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 7.8B | 7.03B | 5.05B |
| INR | 47.65M | 37.88M | 22.21M |
| INR | 323.68M | 257.01M | 157.72M |
| INR | 392.11M | 305.4M | 216.29M |
| INR | 102.8M | 71.68M | 57.46M |
| INR | 290.35M | 233.03M | 158.83M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.